{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:36:40Z","timestamp":1783373800315,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001554","name":"Massey University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bja.2024.11.043","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:28:37Z","timestamp":1738261717000},"page":"317-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathogenicity assessment of seven RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia in the Netherlands"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-3267","authenticated-orcid":false,"given":"Luuk R.","family":"van den Bersselaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4660-0979","authenticated-orcid":false,"given":"Anja H.","family":"Schiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Ya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-7295","authenticated-orcid":false,"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-8667","authenticated-orcid":false,"given":"Ignacio","family":"Malagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert-Jan","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Bjorksten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-0349","authenticated-orcid":false,"given":"Robyn","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4455-6401","authenticated-orcid":false,"given":"Anna","family":"Hellblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6480-1892","authenticated-orcid":false,"given":"Erik-Jan","family":"Kamsteeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4125-6187","authenticated-orcid":false,"given":"Marc M.J.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-7211","authenticated-orcid":false,"given":"Kathryn M.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2024.11.043_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2024.11.043_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","article-title":"Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands","volume":"118","author":"Riazi","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.11.043_bib3","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1213\/ANE.0000000000000421","article-title":"Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States","volume":"119","author":"Larach","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.11.043_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.11.043_bib5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group","volume":"56","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.11.043_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0000000000004199","article-title":"Referral indications for malignant hyperthermia susceptibility diagnostics in patients without adverse anesthetic events in the era of next-generation sequencing","volume":"136","author":"van den Bersselaar","year":"2022","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.11.043_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bja.2018.06.028","article-title":"Genetic epidemiology of malignant hyperthermia in the UK","volume":"121","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.11.043_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","article-title":"Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility","volume":"97","author":"Monnier","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.11.043_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2024.11.043_bib10","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2024.11.043_bib11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-021-01125-w","article-title":"Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility","volume":"23","author":"Johnston","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2024.11.043_bib13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bja.2022.08.029","article-title":"Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia","volume":"129","author":"White","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.11.043_bib14","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/j.bja.2021.05.008","article-title":"RYR1 variant c.38T>G, p.Leu13Arg causes hypersensitivity of the ryanodine receptor-1 and is pathogenic for malignant hyperthermia","volume":"127","author":"van den Bersselaar","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.11.043_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bja.2024.11.043_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.bja.2024.11.043_bib17","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study","volume":"9","author":"Klingler","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bja.2024.11.043_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac292","article-title":"Neuromuscular symptoms in patients with RYR1-related malignant hyperthermia and rhabdomyolysis","volume":"4","author":"van den Bersselaar","year":"2022","journal-title":"Brain Commun"},{"key":"10.1016\/j.bja.2024.11.043_bib19","doi-asserted-by":"crossref","DOI":"10.3233\/JND-230018","article-title":"Muscle ultrasound abnormalities in individuals with RYR1-related malignant hyperthermia susceptibility","author":"van den Bersselaar","year":"2023","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.bja.2024.11.043_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/ene.12713","article-title":"RYR1-related myopathies: a wide spectrum of phenotypes throughout life","volume":"22","author":"Snoeck","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bja.2024.11.043_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/ene.14553","article-title":"The etiology of rhabdomyolysis: an interaction between genetic susceptibility and external triggers","volume":"28","author":"Kruijt","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bja.2024.11.043_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nmd.2017.02.008","article-title":"Resequencing array for gene variant detection in malignant hyperthermia and butyrylcholinestherase deficiency","volume":"27","author":"Levano","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.bja.2024.11.043_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archneur.61.1.106","article-title":"Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization","volume":"61","author":"Guis","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bja.2024.11.043_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.20231","article-title":"Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility","volume":"26","author":"Monnier","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2024.11.043_bib25","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1093\/hmg\/ddac145","article-title":"Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility","volume":"31","author":"Johnston","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bja.2024.11.043_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1862346","article-title":"Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia","volume":"253","author":"Fujii","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bja.2024.11.043_bib27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","article-title":"Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families","volume":"119","author":"Kim","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.11.043_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/bja\/aew065","article-title":"Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia","volume":"117","author":"Schiemann","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2024.11.043_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature14063","article-title":"Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution","volume":"517","author":"Yan","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bja.2024.11.043_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.str.2023.04.009","article-title":"Allosteric modulation of ryanodine receptor RyR1 by nucleotide derivatives","volume":"31","author":"Cholak","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.bja.2024.11.043_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cell.2016.08.075","article-title":"Structural basis for gating and activation of RyR1","volume":"167","author":"des Georges","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bja.2024.11.043_bib32","doi-asserted-by":"crossref","DOI":"10.1085\/jgp.202213230","article-title":"A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery","volume":"154","author":"Murayama","year":"2022","journal-title":"J Gen Physiol"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224007736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224007736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:24:01Z","timestamp":1780118641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091224007736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0007091224007736"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2024.11.043","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenicity assessment of seven RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2024.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}